Cargando…

Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea

Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort,...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schewick, Cornelia M., Nöltner, Christina, Abel, Svenja, Burns, Siobhan O., Workman, Sarita, Symes, Andrew, Guzman, David, Proietti, Michele, Bulashevska, Alla, Moreira, Fernando, Soetedjo, Veronika, Lowe, David M., Grimbacher, Bodo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412961/
https://www.ncbi.nlm.nih.gov/pubmed/32849570
http://dx.doi.org/10.3389/fimmu.2020.01654
_version_ 1783568712380448768
author van Schewick, Cornelia M.
Nöltner, Christina
Abel, Svenja
Burns, Siobhan O.
Workman, Sarita
Symes, Andrew
Guzman, David
Proietti, Michele
Bulashevska, Alla
Moreira, Fernando
Soetedjo, Veronika
Lowe, David M.
Grimbacher, Bodo
author_facet van Schewick, Cornelia M.
Nöltner, Christina
Abel, Svenja
Burns, Siobhan O.
Workman, Sarita
Symes, Andrew
Guzman, David
Proietti, Michele
Bulashevska, Alla
Moreira, Fernando
Soetedjo, Veronika
Lowe, David M.
Grimbacher, Bodo
author_sort van Schewick, Cornelia M.
collection PubMed
description Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort, including symptoms, infections, level of inflammation, and microbial diversity. Methods: A cross-sectional study of adult CVID patients (139 out of 172 diagnosed with CVID completed the screening questionnaire). Those with diarrhoea ≥6 days/month had stool and blood samples analysed and completed the short Inflammatory Bowel Disease Questionnaire (sIBDQ). BMI, spleen-size, lymphocytes and gut-microbial diversity were compared. Due to logistical and clinical restraints, not all patients could be analysed on all measures. Results: 46/139 (33.1%) patients had current significant diarrhoea. In patients with past or present diarrhoea, BMI was lower (median 23.7 vs. 26, p = 0.005), malabsorption more common (57.97 vs. 35.71%, p = 0.011). CD4+ lymphocytes were higher in patients with diarrhoea (p = 0.028; n = 138), but CD4+ naïve lymphocytes were significantly higher in non-diarrhoea patients (p = 0.009, N = 28). Nine patients had confirmed or probable current gastrointestinal infections. Calprotectin was >60 μg/g in 13/29 with significant diarrhoea including 9 without infection. SIBDQ revealed a low median score of 4.74. Microbial alpha diversity was significantly lower in CVID patients compared to healthy household controls. There was no significant difference in alpha diversity in relation to antibiotic intake during the 6 weeks prior to providing samples. Conclusion: Patients with CVID and significant diarrhoea had infections, raised calprotectin, malabsorption, a lower BMI, an impaired quality of life (comparable to active IBD), and they differed from non-diarrhoea patients in their lymphocyte phenotyping. Furthermore, microbial diversity was altered. These findings strongly imply that there may be an inflammatory nature and a systemic predisposition to diarrhoea in CVID, which necessitates further investigation.
format Online
Article
Text
id pubmed-7412961
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74129612020-08-25 Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea van Schewick, Cornelia M. Nöltner, Christina Abel, Svenja Burns, Siobhan O. Workman, Sarita Symes, Andrew Guzman, David Proietti, Michele Bulashevska, Alla Moreira, Fernando Soetedjo, Veronika Lowe, David M. Grimbacher, Bodo Front Immunol Immunology Background: Diarrhoea is the commonest gastrointestinal symptom in patients with common variable immunodeficiency (CVID). Objective: The aim of this study was to describe the prevalence and clinical presentation of chronic and recurrent diarrhoea in the Royal-Free-Hospital (RFH) London CVID cohort, including symptoms, infections, level of inflammation, and microbial diversity. Methods: A cross-sectional study of adult CVID patients (139 out of 172 diagnosed with CVID completed the screening questionnaire). Those with diarrhoea ≥6 days/month had stool and blood samples analysed and completed the short Inflammatory Bowel Disease Questionnaire (sIBDQ). BMI, spleen-size, lymphocytes and gut-microbial diversity were compared. Due to logistical and clinical restraints, not all patients could be analysed on all measures. Results: 46/139 (33.1%) patients had current significant diarrhoea. In patients with past or present diarrhoea, BMI was lower (median 23.7 vs. 26, p = 0.005), malabsorption more common (57.97 vs. 35.71%, p = 0.011). CD4+ lymphocytes were higher in patients with diarrhoea (p = 0.028; n = 138), but CD4+ naïve lymphocytes were significantly higher in non-diarrhoea patients (p = 0.009, N = 28). Nine patients had confirmed or probable current gastrointestinal infections. Calprotectin was >60 μg/g in 13/29 with significant diarrhoea including 9 without infection. SIBDQ revealed a low median score of 4.74. Microbial alpha diversity was significantly lower in CVID patients compared to healthy household controls. There was no significant difference in alpha diversity in relation to antibiotic intake during the 6 weeks prior to providing samples. Conclusion: Patients with CVID and significant diarrhoea had infections, raised calprotectin, malabsorption, a lower BMI, an impaired quality of life (comparable to active IBD), and they differed from non-diarrhoea patients in their lymphocyte phenotyping. Furthermore, microbial diversity was altered. These findings strongly imply that there may be an inflammatory nature and a systemic predisposition to diarrhoea in CVID, which necessitates further investigation. Frontiers Media S.A. 2020-07-31 /pmc/articles/PMC7412961/ /pubmed/32849570 http://dx.doi.org/10.3389/fimmu.2020.01654 Text en Copyright © 2020 van Schewick, Nöltner, Abel, Burns, Workman, Symes, Guzman, Proietti, Bulashevska, Moreira, Soetedjo, Lowe and Grimbacher. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
van Schewick, Cornelia M.
Nöltner, Christina
Abel, Svenja
Burns, Siobhan O.
Workman, Sarita
Symes, Andrew
Guzman, David
Proietti, Michele
Bulashevska, Alla
Moreira, Fernando
Soetedjo, Veronika
Lowe, David M.
Grimbacher, Bodo
Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title_full Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title_fullStr Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title_full_unstemmed Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title_short Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
title_sort altered microbiota, impaired quality of life, malabsorption, infection, and inflammation in cvid patients with diarrhoea
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412961/
https://www.ncbi.nlm.nih.gov/pubmed/32849570
http://dx.doi.org/10.3389/fimmu.2020.01654
work_keys_str_mv AT vanschewickcorneliam alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT noltnerchristina alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT abelsvenja alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT burnssiobhano alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT workmansarita alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT symesandrew alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT guzmandavid alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT proiettimichele alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT bulashevskaalla alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT moreirafernando alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT soetedjoveronika alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT lowedavidm alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea
AT grimbacherbodo alteredmicrobiotaimpairedqualityoflifemalabsorptioninfectionandinflammationincvidpatientswithdiarrhoea